A phase II trial of gefitinib (Iressa, ZD1839) in stage IV and recurrent renal cell carcinoma (Q34553224)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A phase II trial of gefitinib (Iressa, ZD1839) in stage IV and recurrent renal cell carcinoma
scientific article

    Statements

    A phase II trial of gefitinib (Iressa, ZD1839) in stage IV and recurrent renal cell carcinoma (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit